Background: Circular RNAs (circRNAs) are recently found involved in cancer occurrence and development. However, their values in the diagnosis of gastric cancers are largely unknown. In this study, we analyzed the values of hsa_circ_0000181 in the diagnosis of gastric cancer.
Methods:
Using divergent primers, hsa_circ_0000181 expression levels in fresh gastric cancer tissues and paired adjacent non-tumorous tissues, and plasmas from patient with gastric cancer and health people were detected by real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The association between hsa_circ_0000181 levels and the clinicopathologic features of patients with gastric cancer was further analyzed. Finally, to evaluate the diagnostic value, receiver operating characteristic (ROC) curve was established.
Results: Hsa_circ_0000181 levels in gastric cancer tissues and plasma from gastric cancer patients were significantly decreased than those in paired adjacent nontumorous tissues (P < .001) and healthy people (P < .001), respectively. Furthermore, hsa_circ_0000181 expression in gastric cancer tissues was significantly correlated with tumor diameter (P = .027), lymphatic metastasis (P = .044), distal metastasis (P = .023), and carbohydrate antigen 19-9 (P = .031). Its decreased levels in patients' plasma were significantly associated with differentiation (P = .038) and carcinoembryonic antigen (P = .037). The areas under ROC curve were 0.756. The specificity of tissue hsa_circ_0000181 and sensitivity of plasma hsa_circ_0000181 were 85.2% and 99.0%, respectively.
Conclusions:
Thanks to the high stability, tissue and plasma hsa_circ_0000181 may be a novel biomarker for the diagnosis of gastric cancer.
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| INTRODUCTION
Circular RNAs (circRNAs) are a class of noncoding RNAs with stable structure and high tissue/developmental-stage specificity. 1 They were first found in viroidal plant pathogens and then found commonly in mammalian cells. 2 CircRNAs are generated by backsplicing events as loops without a free 3′ or 5′ ends. nlm.nih.gov/geo/query/acc.cgi?acc = GSE89143). 12 In this study, we first verified that hsa_circ_0000181 levels were significantly changed in gastric cancer tissues and plasmas from gastric cancer patients.
Moreover, we found that its expression levels were significantly associated with several clinicopathologic features of patients with gastric cancer. The results indicated that hsa_circ_0000181 might be used as a novel biomarker of gastric cancer.
| MATERIALS AND METHODS

| Patients and sample collection
A total of 115 fresh gastric cancer tissues and paired adjacent non- at −80°C until use. The adjacent tissues were about 5 cm from cancer edge. They were assessed by two pathologists and confirmed non-tumorous tissues. What's more, no radiotherapy or chemotherapy was applied to these patients. Before any treatment was applied, we collected 102 patients' fasting peripheral plasmas (3 mL) with ethylenediaminetetraacetic acid (EDTA) as the anticoagulant.
According to the age-and gender-matched standard, we further collected fresh fasting plasmas from 105 healthy people at Ningbo
No. 2 Hospital, China, at February 2016. Immediately obtained, the plasma was centrifuged and then stored at −80°C until use as previously described. 13 Tumors were staged according to the tumor-node-metastasis (TNM) staging system of the International Union Against Cancer. 
| Total RNA extraction
According to the manufacturer's instructions, total RNA of tissue samples and plasma samples were first extracted by TRIzol reagent and TRIzol LS Reagent (Invitrogen, Karlsruhe, Germany), respectively.
Then, the concentration and purity of total RNA were measured by DeNovix DS-11 Spectrophotometer (DeNovix, Wilmington, DE, USA).
Finally, RNA was stored at −80°C till use.
| Reverse transcription
Using the GoScript RT System (Promega, Madison, WI, USA), cDNA was transcripted as previously described. 15 
| qRT-PCR detection of hsa_circ_0000181
The polymerase chain reaction (PCR) was performed using GoTaq qPCR master mix (Promega) on the Mx3005P QPCR System Through two independent experiments, all results were expressed as the mean ± SD. we analyzed the differences of hsa_circ_0000181 expression levels between cancer tissues and adjacent non-tumor tissues, and between plasma samples from gastric cancer patients and healthy controls.
| Statistical analysis
By one-way analysis of variance (ANOVA), we further evaluated the correlation between hsa_circ_0000181 levels and clinicopathologic factors of patients with gastric cancer. The receiver operating characteristic (ROC) curve was established to evaluate the diagnostic value.
P < .05 was considered to have significant difference.
| RESULTS
| Hsa_circ_0000181 expression was downregulated in gastric cancer tissues and plasma of patients with gastric cancer
By qRT-PCR, we measured hsa_circ_0000181 levels in tissues and plasma. The results showed that its levels in gastric cancer tissues were significantly lower than those in adjacent non-tumorous tissues (P < .001; Figure 1A ). Moreover, we found that hsa_circ_0000181 levels were decreased in plasma from patients with gastric cancer comparing with controls (P = .001; Figure 1B ).
| Diagnostic values of hsa_circ_0000181 in gastric cancer
As what was shown in Figure 1 , we found that hsa_circ_0000181
was significantly downregulated in gastric cancer tissues as well as in plasma. As a result, we further evaluated its diagnostic values for
As what is shown in Table 1 , hsa_circ_0000181 expression levels in gastric cancer tissues were significantly related to tumor diameter (P = .027), distal metastasis (P = .023), lymphatic metastasis (P = .044), and CA19-9 level (P = .031). To better assess the diagnostic values, a ROC curve was made. The area under the ROC curve (AUC) in tissues was 0.756 (P < .0001; Figure 2 ). And the specificity and sensitivity were 85.2% and 53.9%, respectively. The false-positive rate and false-negative rate were 14.8% and 46.1%, respectively. The negative predictive value (NPV) and positive predictive value (PPV) were 64.9%
and 78.5%, respectively. The cutoff value was 9.40.
As shown in Table 2 , hsa_circ_0000181 levels in plasma of patients with gastric cancer were associated with CEA level (P = .037) and differentiation (P = .038). These findings indicated that patients with positive CEA expression had higher hsa_circ_0000181 levels. In addition, the AUC of hsa_circ_0000181 in plasma was 0.582 (P < .05; Figure 2 ).
The specificity and sensitivity were 20.6% and 99.0%, respectively.
The false-negative rate and false-positive rate were 1% and 79.4%, respectively. The NPV and PPV were 99.5% and 11.1%, respectively.
The cutoff value was 7.27.
| DISCUSSION
CircRNAs were first discovered in RNA viruses as early as the 1970s using electron microscopy. 17 In the following years, due to the development of high-throughput RNA sequencing (RNA-Seq) technology and bioinformatics methods, more and more circRNAs have been found. According to their origin, we can divide circRNAs into three major categories: intron-derived circRNAs, back-spliced exons formed circRNA, and exon-intron circRNA or EIciRNA.
18-20
CircRNAs are expressed in human cells in a tissue/developmentalstage specificity, and sometimes their expression levels can be 10 times higher than their associated linear isoforms. 1, 21 CircRNAs have two most important properties: highly conserved and high stability.
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With these two significant properties, circRNAs may be served as better biomarkers in diagnosing cancer in comparison with other noncoding RNAs.
By now, functions of some circRNAs have been revealed. For example, ciRS-7 (circular RNA sponge for miR-7) contains about 70 conserved miRNA target sites with miR-7, which can forcefully suppress miR-7 activity. 23 Some researchers found that miR-7 suppressed the growth of non-small-cell lung cancer (NSCLC) cells
24
; others found that miR-7 acted as a therapeutic target in Parkinson's disease. 25 In addition, miR-7 inhibitors promoted pancreatic β-cell replication through mTOR signaling pathway. 26 Thus, acting as a miR-7 sponge, ciRS-7 may directly or indirectly participate in occurrence and development of human diseases.
Another famous circRNA is circular antisense noncoding RNA in the INK4 locus (cANRIL). The single nucleotide polymorphism (SNP) F I G U R E 1 Hsa_circ_0000181 expression levels in gastric cancer tissues (A) and plasma (B) from patients with gastric cancers. The qRT-PCR method was first used to detect hsa_circ_0000181 and GAPDH levels. Then, ΔC q method was used to analyze the relative level of hsa_ circ_0000181. P < .001, n = 115. Higher ΔC q value indicates lower expression
in cANRIL gene is associated with the risk of atherosclerotic vascular disease (ASVD). 27 This means that circRNAs may play an important role in the progression of tumors or other diseases.
Although more and more circRNAs have been identified, the diagnostic values of most circRNAs are still largely unknown. In this study,
for the first time, we found that hsa_circ_0000181 was downregulated in the gastric cancer tissues and plasma from gastric cancer patients (Figure 1 ). Furthermore, we found its potential diagnostic value in gastric cancer (Figure 2 ).
The lymphatic metastasis, tumor size, and distal metastasis are important factors affecting prognosis of gastric cancer. [28] [29] [30] [31] Patients with lymphatic metastasis have lower 5-year survival rate. 30 Larger tumor size contributes to a poor survival rate of 5 years of patients with gastric cancer. 28 Distal metastasis is also a factor of decreasing 5-year survival rate. 31 In our study, we found that low expression of hsa_circ_0000181 in gastric cancer tissue was related to tumor size, distal metastasis, and lymphatic metastasis (Table 1) . Patients having higher hsa_circ_0000181 expression levels have higher rate of distal metastasis ( Table 1) . As a tissue-based biomarker, hsa_circ_0000181
had a higher specificity (85.2%), as well as a high PPV (78.5%) and NPV (64.9%).
It was reported that differentiation also contributes to 5-year survival rate. 32 Interestingly, we found that hsa_circ_0000181 levels were correlated with differentiation (Table 2) . Patients with lower differentiation had lower hsa_circ_0000181 levels. In addition, hsa_ circ_0000181 levels also associated with blood CEA levels ( Table 2 ).
These mean that as a plasma-based biomarker, hsa_circ_0000181
should be considered as a noninvasive biomarker of gastric cancer.
Nowadays, CEA and CA19-9 have been widely used as plasmabased biomarkers for the diagnosis of gastric cancer and other tumors. 9,11,33 However, they have low sensitivity and specificity. A study indicated that CEA's sensitivity and specificity were 68.6% and 59.3%, respectively; and for CA19-9, 60.5% and 55.9%, respectively. 34 In comparison with CEA and CA19-9, hsa_circ_0000181 had a higher sensitivity in screening gastric cancer (Figure 2 ).
The limitation of this study is that it is only a relative small sample study. It would be better if initial validation on a smaller cohort of patients (Training set) followed by a larger cohort of patients (Validation set).
In conclusion, our data suggest that hsa_circ_0000181 may be served as a novel biomarker in the diagnosis of gastric cancer. 
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